Corcept Therapeutics Shares Outstanding 2006-2018 | CORT

Corcept Therapeutics shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Corcept Therapeutics Annual Shares Outstanding
(Millions of Shares)
2017 125
2016 116
2015 107
2014 101
2013 100
2012 93
2011 83
2010 68
2009 52
2008 47
2007 34
2006 23
2005 23
Corcept Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 126
Q2 2018 128
Q1 2018 128
Q4 2017 125
Q3 2017 126
Q2 2017 123
Q1 2017 121
Q4 2016 116
Q3 2016 116
Q2 2016 115
Q1 2016 110
Q4 2015 107
Q3 2015 108
Q2 2015 108
Q1 2015 102
Q4 2014 101
Q3 2014 101
Q2 2014 101
Q1 2014 101
Q4 2013 100
Q3 2013 100
Q2 2013 100
Q1 2013 100
Q4 2012 93
Q3 2012 99
Q2 2012 89
Q1 2012 84
Q4 2011 83
Q3 2011 84
Q2 2011 84
Q1 2011 81
Q4 2010 68
Q3 2010 72
Q2 2010 66
Q1 2010 63
Q4 2009 52
Q3 2009 50
Q2 2009 50
Q1 2009 50
Q4 2008 47
Q3 2008 49
Q2 2008 48
Q1 2008 40
Q4 2007 34
Q3 2007 37
Q2 2007 35
Q1 2007 26
Q4 2006 23
Q3 2006 23
Q2 2006 23
Q1 2006 23
Q4 2005 23
Q3 2005 23
Q2 2005 23
Q1 2005 23
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.784B $0.159B
Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol. It is developing its lead product, CORLUX for the treatment of the psychotic features of psychotic major depression. Corcept Therapeutics Incorporated is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $39.978B 27.37
Takeda Pharmaceutical (TAK) Japan $30.466B 14.23
Grifols (GRFS) Spain $13.119B 15.90
Neurocrine Biosciences (NBIX) United States $7.978B 1759.60
Tilray (TLRY) United States $7.976B 0.00
Ionis Pharmaceuticals (IONS) United States $7.866B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.731B 11.10
Nektar Therapeutics (NKTR) United States $7.723B 11.07
Loxo Oncology (LOXO) United States $7.141B 0.00
Sage Therapeutics (SAGE) United States $6.358B 0.00
Catalent (CTLT) United States $5.034B 21.12
United Therapeutics (UTHR) United States $4.952B 8.10
FibroGen (FGEN) United States $4.306B 0.00
TESARO (TSRO) United States $4.122B 0.00
Impax Laboratories (AMRX) United States $3.711B 19.73
Taro Pharmaceutical Industries (TARO) Israel $3.612B 13.37
USANA Health Sciences (USNA) United States $2.805B 23.88
Endo (ENDP) Ireland $2.167B 3.32
Heron Therapeutics (HRTX) United States $2.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.064B 0.00
Xencor (XNCR) United States $1.944B 0.00
Aerie Pharmaceuticals (AERI) United States $1.916B 0.00
Zogenix (ZGNX) United States $1.761B 0.00
PTC Therapeutics (PTCT) United States $1.759B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.739B 0.00
Portola Pharmaceuticals (PTLA) United States $1.696B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.576B 213.00
Theravance Biopharma (TBPH) Cayman Islands $1.476B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.429B 20.11
Arrowhead Pharmaceuticals (ARWR) United States $1.338B 0.00
TherapeuticsMD (TXMD) United States $1.232B 0.00
Esperion Therapeutics (ESPR) United States $1.153B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.119B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.011B 0.00
Tricida (TCDA) United States $0.952B 0.00
Radius Health (RDUS) United States $0.747B 0.00
ImmunoGen (IMGN) United States $0.744B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.624B 0.00
ChemoCentryx (CCXI) United States $0.617B 48.88
Karyopharm Therapeutics (KPTI) United States $0.597B 0.00
Siga Technologies (SIGA) United States $0.597B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.566B 0.00
Collegium Pharmaceutical (COLL) United States $0.528B 0.00
Flexion Therapeutics (FLXN) United States $0.507B 0.00
Forty Seven (FTSV) United States $0.493B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.468B 27.58
GlycoMimetics (GLYC) United States $0.461B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.450B 0.00
Odonate Therapeutics (ODT) United States $0.441B 0.00
ArQule (ARQL) United States $0.416B 0.00
Tyme Technologies (TYME) United States $0.361B 0.00
CASI Pharmaceuticals (CASI) United States $0.359B 0.00
Xeris Pharmaceuticals (XERS) United States $0.358B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.357B 0.00
Akebia Therapeutics (AKBA) United States $0.353B 0.00
Majesco Entertainment (PTE) United States $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.327B 0.00
KalVista Pharmaceuticals (KALV) United States $0.326B 0.00
OptiNose (OPTN) United States $0.305B 0.00
Lannett Co Inc (LCI) United States $0.296B 2.56
Dermira (DERM) United States $0.282B 0.00
Minerva Neurosciences (NERV) United States $0.280B 0.00
Depomed (ASRT) United States $0.270B 10.05
Verrica Pharmaceuticals (VRCA) United States $0.269B 0.00
Tapimmune (MRKR) United States $0.268B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.266B 0.00
Aclaris Therapeutics (ACRS) United States $0.264B 0.00
Mast Therapeutics (SVRA) United States $0.260B 0.00
IMV INC (IMV) Canada $0.259B 0.00
Translate Bio (TBIO) United States $0.255B 0.00
Aldeyra Therapeutics (ALDX) United States $0.235B 0.00
Opexa Therapeutics (ACER) United States $0.232B 0.00
Dova Pharmaceuticals (DOVA) United States $0.226B 0.00
Affimed (AFMD) Germany $0.224B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.210B 0.00
MEI Pharma (MEIP) United States $0.201B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.201B 0.00
Aratana Therapeutics (PETX) United States $0.199B 0.00
Galectin Therapeutics (GALT) United States $0.194B 0.00
Aquestive Therapeutics (AQST) United States $0.191B 0.00
Zafgen (ZFGN) United States $0.174B 0.00
Molecular Templates (MTEM) United States $0.174B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.172B 0.00
Recro Pharma (REPH) United States $0.168B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
Ocular Therapeutix (OCUL) United States $0.163B 0.00
Jounce Therapeutics (JNCE) United States $0.160B 0.00
Rafael Holdings (RFL) United States $0.160B 0.00
Nature's Sunshine Products (NATR) United States $0.152B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.152B 0.00
Redhill Biopharma (RDHL) Israel $0.148B 0.00
Neon Therapeutics (NTGN) United States $0.146B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.145B 0.00
Adherex Technologies (FENC) United States $0.142B 0.00
Ardelyx (ARDX) United States $0.139B 0.00
ElectroCore (ECOR) United States $0.138B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.137B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.135B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.124B 0.00
MediWound (MDWD) Israel $0.122B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.119B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.114B 0.00
Champions Oncology (CSBR) United States $0.109B 0.00
DURECT (DRRX) United States $0.102B 0.00
ProNAi Therapeutics (SRRA) Canada $0.100B 0.00
Aptorum Group (APM) China $0.099B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.095B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.093B 0.00
Natural Alternatives (NAII) United States $0.083B 8.15
Iterum Therapeutics (ITRM) Ireland $0.082B 0.00
Cardiome Pharma (CORV) Canada $0.081B 0.00
Nivalis Therapeutics (ALPN) United States $0.080B 0.00
Infinity Pharmaceuticals (INFI) United States $0.076B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.076B 0.00
CTI BioPharma (CTIC) United States $0.074B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
KemPharm (KMPH) United States $0.070B 0.00
Avenue Therapeutics (ATXI) United States $0.068B 0.00
Immune Design (IMDZ) United States $0.067B 0.00
Neos Therapeutics (NEOS) United States $0.065B 0.00
BioLineRx (BLRX) Israel $0.065B 0.00
Otonomy (OTIC) United States $0.062B 0.00
Achaogen (AKAO) United States $0.061B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.059B 0.00
Melinta Therapeutics (MLNT) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.053B 0.00
Genocea Biosciences (GNCA) United States $0.053B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
ContraFect (CFRX) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
Novan (NOVN) United States $0.041B 0.00
Capnia (SLNO) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Lipocine (LPCN) United States $0.034B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
PharmAthene (ALT) United States $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.025B 0.00
ESSA Pharma (EPIX) Canada $0.025B 0.00
Trillium Therapeutics (TRIL) Canada $0.024B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Biomerica (BMRA) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Aviragen Therapeutics (VXRT) United States $0.016B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.015B 0.00
Shineco (TYHT) China $0.013B 1.45
Onconova Therapeutics (ONTX) United States $0.012B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00